SCHEMBL6537536

SCHEMBL6537536

O=C(Nc1cccc2cc(Br)cnc12)c1c(Cl)cccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.52
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 3/20 0.47
MAPT P10636 3/20 0.47
PLEC Q15149 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
TP53 P04637 1/20 0.46
GAA P10253 1/20 0.45
LMNA P02545 1/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
JAK2 O60674 2/20 0.43
TYK2 P29597 2/20 0.43
JAK1 P23458 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537606 0.88 KDR (0.67) KDRTDP1L3MBTL1MAPTPLEC
SCHEMBL6537382 0.85 SLC40A1 (0.52) KDRL3MBTL1MAPTPLECMEN1
SCHEMBL6537320 0.84 KDR (0.47) KDRL3MBTL1MAPTPLECMEN1
SCHEMBL6538190 0.84 KDR (0.67) KDRTDP1L3MBTL1MAPTMEN1
SCHEMBL6538256 0.84 MAPT (0.52) KDRL3MBTL1MAPTPLECMEN1
SCHEMBL6537743 0.82 KDR (0.48) KDRL3MBTL1MAPTPLECMEN1
SCHEMBL6537334 0.82 L3MBTL1 (0.70) KDRTDP1L3MBTL1MAPTMEN1
SCHEMBL6537425 0.82 KDR (0.51) KDRL3MBTL1MAPTPLECMEN1
SCHEMBL6537852 0.82 KDR (0.48) KDRL3MBTL1MAPTPLECMEN1
SCHEMBL6537399 0.82 KDR (0.49) KDRL3MBTL1MAPTPLECMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed